References
- Kent AR, Nussdorf JD, David R, Tyson F, Small D, Fellows D. Vitreous concentration of topically applied bri-monidine tartrate 0.2%. Ophthalmology.2001;108:784–787.
- Peyman GA, May DR, Homer PI, Kasbeer RT. Penetration of gentamicin into the aphakic eye. Ann Ophthalmol.1977;9:871–880.
- Green K, Bowman K, Luxenberg MN, Friberg TR. Pene-tration of topical indomethacin into phakic and aphakic rabbit eyes. Arch Ophthalmol.1983;101:284–288.
- Araie M, Takase M, Sakai Y, Ishii Y, Yokoyama Y, Kitagawa M. Beta-adrenergic blockers: Ocular penetration and binding to the uveal pigment. Jpn J Ophthalmol.1982;26: 248–263.
- Maurice DM. Structures and fluids involved in the pene-tration of topically applied drugs. Int Ophthalmol Clin.1980;20:7–20.
- Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M. Vasoactive and 0-adrenoceptor blocking properties of 3,4 -dihydro - 8 - (2 -hydroxy-3 s opropyl amino )propoxy - 3-nitroxy-2H-1-benzopyran (K-351), a new antihyperten-sive agent. Arch Int Pharmacodyn Ther.1983;262: 132–149.
- Kanno M, Araie M, Koibuchi H, Masuda K. Effects of topical nipradilol, a beta blocking agent with alpha block-ing and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br J Ophthalmol.2000;84:293–299.
- Masuda K, Takase M, Kitazawa Y, Shiose Y, Azuma I, Ogawa N, Ohdo S. Phase III comparative clinical study on KT-210 in patients with primary open-angle glaucoma and ocular hypertension. Multicenter cooperative between-group comparative double-blind clinical trial with 0.5% timolol maleate ophthalmic solution. Atarashii Ganka (Journal of the Eye).1996;13: 1771–1783.
- Yamada Y, Ito K, Nakamura K, Sawada Y, Iga T. Predictionof therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/ pharmacodynamic relationship. Biol Pharm Bull.1993;16: 1251–1259.
- Koide T, Fujino H, Yoshimura M, Kimata H, Takao A, Honda S, Yamashita K, Hon i K, Ishiguro Y, Orihashi M. Metabolic fate of [14C] KT-210 (Nipradilol ophthalmic solution) in rabbits (1); Absorption, distribution, metabo-lism and excretion after instillation, and absorption, ex-cretion after intravenous administration to rabbits. Jpn Pharmacol Ther.1996;24supp1.8: 53–65.
- Yoshimura M, Kojima J, Ito T, Suzuki J. Structural deter-mination of dog and human urinary metabolites of nipradilol (K-351): A new antihypertensive agent. Chem Pharm Bull.1985;33:3456–3468.
- McCartney MD, Cantu-Crouch D. Rabbit corneal epithelial wound repair: Tight junction reformation. Curr Eye Res.1992;11:15–24.
- Yoshimura M, Kojima J, Ito T, Suzuki J. Pharmacokinetics of nipradilol (K-351): A new antihypertensive agent. I. Studies on interspecies variation in laboratory animals. J Pharmacobiodyn.1985;8:738–750.
- Yoshimura M, Kojima J, Ito T, Suzuki J, Tsutsui S, Katou K. Pharmacokinetics of nipradilol (K-351), a new antihy-pertensive agent, in human. Jpn J Clin Pharmacol Ther.1985;16:679–691.
- Mehvar R, Brocks DR. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. J Pharm Pharm Sci.2001;4:185–200.
- Siriwardena D, Kotecha A, Minassian D, Dart JK, Khaw PT. Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol.2000;84:1056–1057.
- Shah SM, Spalton DJ. Changes in anterior chamber flare and cells following cataract surgery. Br J Ophthalmol.1994;78:91–94.
- Tanihara H, Yokoi N, Komuro A, Honda Y, Kinoshita S. Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy. Am J Ophthalmol.1997;123:487–493.
- Lohmann AM, van Best JA, de Keizer RJ. Corneal metab-olism and epithelial barrier function after cataract surgery and intraocular lens implantation: A fluorophotometric study. Int Ophthalmol.1995–96;19:225–233.
- Schultz G, Khaw PT, Oxford K, MaCauley S, Van Setten G, Chegini N. Growth factors and ocular wound healing. Eye.1994;8:184–187.
- Wilson SE, Mohan RR, Mohan RR, Ambrosio R Jr, Hong J, Lee J. The corneal wound healing response: Cytokine-mediated interaction of the epithelium, stroma, and inflam-matory cells. Prog Retin Eye Res.2001;20:625–637.
- Hackam DJ, Ford HR. Cellular, biochemical, and clinical aspects of wound healing. Surg Infect.2002;3:523—S35.
- Okamura T, Kitamura Y, Uchiyama M, Toda M, Ayajiki K, Toda N. Canine retinal arterial and arteriolar dilation induced by nipradilol, a possible glaucoma thrapeutic. Pharmacology.1996;53:302–310.